Stock Screener App

Frei -

Installieren

3.19

1.92% 0.06

Atea Pharmaceuticals Inc (AVIR)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Atea Pharmaceuticals Inc-Aktie (AVIR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	49.89% 69.81	46.57	40.78	35.23	41.57
Depreciation and Amortization	0.00% 0.104	0.104	0.104	0.104	0.104
Operating Income/Loss	49.89% -69.81	-46.57	-40.78	-35.23	-41.57
Income/Loss From Continuing Operations Before Tax	62.15% -62.94	-38.81	-32.92	-27.93	-35.27
Income Tax Expense/Benefit	33.81% 0.231	0.349	0.221	0.251	0.197
Income/Loss From Continuing Operations After Tax	61.29% -63.17	-39.16	-33.14	-28.18	-35.47
Net Income/Loss	61.29% -63.17	-39.16	-33.14	-28.18	-35.47
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	544.03K% 83.92	0.0154	83.40	83.40	83.33
Diluted Average Shares	544.03K% 83.92	0.0154	83.40	83.40	83.33
Basic Earnings Per Share	59.57% -0.75	-0.47	-0.40	-0.34	-0.43
Diluted Earnings Per Share	59.57% -0.75	-0.47	-0.40	-0.34	-0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters